Dr. Dollé is Head of the Chemistry and Radiochemistry section at the Service Hospitalier Frédéric Joliot (SHFJ, Orsay, Paris-area, France), an research infrastructure belonging to the Biomedical Imaging Institute / Life Sciences Division of the French Atomic Energy Commission (CEA). He’s an expert in Medicinal chemistry, radiotracer development and molecular imaging. Strategic goals for his research are based on the identification of new bioimaging targets and associated radioligands for Positron Emission Tomography, their preclinical evaluation and their translation into clinical research and diagnostic tools. Dr. Dollé holds a Ph.D. in organic chemistry from the University of Strasbourg, France and did his postdoctoral work at Sanofi (Former Rhône-Poulenc-Rorer), Research Triangle Park, North Carolina, USA.